We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $182.86 · 14 analysts
Stored first · Google News · Yahoo Finance (English)
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch
Becton Dickinson & Co. stock outperforms competitors on strong trading day MarketWatch
BD to Announce Financial Results for its Third Quarter of Fiscal 2026
The Wide Chasm Priced Into Boston Scientific Stock
Waters Seen Benefiting From BD Turnaround, Pharma Manufacturing Tailwinds, RBC Says
Becton Dickinson (BDX) Stock Trades At A Discount On Cash Flow And Earnings
Becton Dickinson (BDX) Joins New Russell Indexes, Is The Stock Below Fair Value?
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 06. | After market close (AMC) | $3.12 | — | — | $4.89B | — | Scheduled |
| FY2026 Q2 | 2025. 03. 31. | Time TBD | — | $2.11 | — | — | $8.81B | Reported |
| FY2026 Q1 | 2024. 12. 31. | Time TBD | — | $1.04 | — | — | $5.17B | Reported |
| FY2025 Q3 | 2024. 06. 30. | Time TBD | — | $4.49 | — | — | $14.74B | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 11. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2026. 05. 08. | Wells Fargo | — | Maintain | Equal-Weight → Equal-Weight | — | Wells Fargo: Equal-Weight |
| 2026. 05. 05. | TD Cowen | — | Maintain | Hold → Hold | — | TD Cowen: Hold |
| 2026. 04. 18. | Piper Sandler | — | Maintain | Neutral → Neutral | — | Piper Sandler: Neutral |
| 2026. 03. 23. | Argus Research | — | Maintain | Buy → Buy | — | Argus Research: Buy |
| 2026. 02. 12. | Citigroup | — | Maintain | Buy → Buy | — | Citigroup: Buy |
As of FY2026Q2 · Source: SEC/DART + price data
No holdings data to show.